![]() |
||
![]() |
||
Key ReferencesAjasse, D. (1984). Le mal des montagnes. Un essai thérapeutique à double insu à 7700 mètres. La Vie Médicale 19: 749-750. Amato, I. (1993). Sniffing out the origins of Ginkgo-stink. Science 261: 1389. Arenz, A., Klein, M., Fiehe, K. et al. (1993). Occurrence of neurotoxic 4-O-methylpyridoxine in Ginkgo biloba leaves, Ginkgo medications and Japanese Ginkgo food. Planta Medica 62: 548-551. Barth, S.A., Inselmann, G., Engemann, R. et al. (1991). Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetylcysteine. Biochemical Pharmacology 41: 1521-1526. Baudouin, C., Ettaiche, M., Fredj-Reygrobellet, D. et al. (1992). Effects of Ginkgo biloba extracts in a model of tractional retinal detachment. Lens and Eye Toxicity Research 9: 513-519. Badouin, C., Pisella, P.J., Ettaiche, M. et al. (1999). Effects of EGb 761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefes Archives for Clinical and Experimental Ophthalmology 237: 58-66. Bauer, U. (1984). 6-Month double-blind randomized clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Drug Research 34: 716-720. Bazan, H.E.P., Braquet, P., Reddy, S.T.K. et al. (1987). Inhibition of the alkali burn-induced lipoxygenation of arachidonic acid in the rabbit cornea in vivo by a platelet activating facor antagonist. Journal of Ocular Pharmacology 3: 357-365. Bekerecioglu, M., Tercvan, M. and Özyazgan, I. (1998). The effect of Ginkgo biloba extract (EGb 761) as a free radical scavenger on the survival of skin flaps in rats. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 32: 135-139. Blumenthal, M., Busse, W.R., Goldberg, A. et al. (eds.). (1998). The Complete German Commission E Monographs. Austin, TX: American Botanical Council, pp. 136-158. Braquet, P.G., Spinnewyn, B., Braquet, M. et al. (1985). BN 52021 and related compounds: a new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L. Blood Vessels 16: 558-572. Braquet, P. and Hosford, D. (1991). Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. Journal of Ethnopharmacology 32: 135-139. Brautigam, M.R.H., Blommaert, F.A., Verleye, G. et al. (1998). Treatment of age-related complaints with Ginkgo biloba extract: a randomized double blind placebo-controlled study. Phytomedicine 5: 425-434. Brüchert, E. Heinrich, S.E. and Ruf-Kohler, P. (1991). Wirksamkeit von LI 1370 bei älteren patienten mit hirnleistungsschwäche. Multizentrische doppelblindstudie des fachverbandes Deutsche allgemeinärzte. Münchener Medizinische Wochenschrift 133(Suppl. 1): S9-S14. |
||
|
|
||